Halozyme: Underappreciated, Durable Royalty-Driven Growth Beyond 2028 Supports Buy Rating
at www.tipranks.com (Thu, 9-Apr 6:26 AM)
at www.tipranks.com (Wed, 8-Apr 7:00 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Tue, 7-Apr 1:10 PM)
Vertex Pharma in pact with Halozyme for Hypercon drug delivery tech
at seekingalpha.com (Tue, 7-Apr 10:08 AM)
Halozyme Lifts Multi-Year Guidance on Royalty Surge and Strategic Acquisitions
Market Chameleon (Wed, 28-Jan 7:45 AM)
